Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2020 | TERIKIDS study: teriflunomide in pediatric patients with relapsing MS

Tanuja Chitnis • 24 May 2020
EAN 2020
Multiple Sclerosis and Related Disorders Teriflunomide
TERIKIDS

Tanuja Chitnis, MD, FAAN, Massachusetts General Hospital, Boston, MA, discusses the TERIKIDS trial (NCT02201108) looking at the efficacy and safety of teriflunomide in pediatric patients with relapsing forms of multiple sclerosis (MS). This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

More from Tanuja Chitnis

1:13
The impact of the gut microbiota on clinical features in progressive MS
Tanuja Chitnis • 26 Apr 2021
1:11
Severe COVID-19 in pediatric MS patients
Tanuja Chitnis • 26 Apr 2021
0:53
Neurofilament light chain as a biomarker in pediatric MS
Tanuja Chitnis • 26 Apr 2021
1:46
Managing pediatric MS in the current era
Tanuja Chitnis • 26 Apr 2021

Related Videos

3:44
Navigating intra-individual variability for early detection of cognitive decline
Leigh Charvet • 23 Feb 2024
3:26
Acupressure for the management of pain and anxiety in patients with MS
Megan Weigel • 4 Mar 2024
5:42
Mapping the functional interactome in MS lesions to shed light on remyelination failure
Milos Opacic • 5 Mar 2024
5:37
GAIT-HUB: a home-based gait monitoring system for patients with MS
Giuseppina Pilloni • 4 Mar 2024
The content of VJNeurology is intended for healthcare professionals